V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 240011486 | 240014214 | 1.62 | 63.4 | Curative (C) | 2014-08-27 | 2015-04-29 | Trial Unspecified | N | N | 240030536 | TRIAL |
| 240011487 | 240014214 | 1.59 | 62.8 | Curative (C) | null | 2015-03-27 | Trial Unspecified | 2 | Y | 240030536 | TRIAL |
| 240011488 | 240014214 | 0 | 86.7 | Palliative (P) | 2017-07-06 | 2017-07-06 | BEVACIZUMAB + CARBO + PACLITAXEL | 02 | N | 240030536 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240011489 | 240014214 | 1.62 | 121 | Curative (C) | 2013-09-12 | 2013-09-19 | INTERLACE TRIAL | N | N | 240030536 | INTERLACE TRIAL |
| 240011490 | 240007690 | 1.67 | null | Curative (C) | null | 2016-06-04 | CARBOPLATIN | 02 | N | 240030551 | CARBOPLATIN |
| 240011491 | 240007690 | null | 77.9 | Palliative (P) | 2013-06-17 | 2013-06-24 | Paclitaxel 7 day | N | N | 240030551 | PACLITAXEL |
| 240011492 | 240007691 | 1.8 | null | Disease modification (D) | 2015-10-22 | 2015-10-22 | Trial Unspecified | N | N | 240030577 | TRIAL |
| 240011493 | 240012131 | 1.84 | 92 | Curative (C) | 2017-05-15 | 2017-05-15 | ALCL ALCL 99 Closed BM 1, 2 or 3 | N | N | 240030579 | NOT MATCHED |
| 240011494 | 240014215 | 1.66 | null | Curative (C) | 2013-06-02 | 2013-09-01 | CHEMO-T TRIAL | N | N | 240030584 | TRIAL |
| 240011495 | 240007692 | 1.56 | 69.4 | null | 2017-11-06 | 2017-11-06 | PACLITAXEL | 02 | N | 240030587 | PACLITAXEL |
| 240011496 | 240012132 | null | 76.2 | Curative (C) | 2016-10-19 | 2016-10-21 | INTERLACE TRIAL | 02 | N | 240030594 | INTERLACE TRIAL |
| 240011497 | 240014216 | null | 64 | Curative (C) | 2015-11-02 | 2015-11-06 | BEVACIZUMAB + CARBO + PACLITAXEL | N | N | 240030601 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240011498 | 240014216 | 1.58 | 63.9 | null | 2016-01-15 | 2016-01-15 | PACLITAXEL | 02 | N | 240030601 | PACLITAXEL |
| 240011499 | 240007696 | 1.74 | 78.2 | null | 2015-11-26 | 2015-11-30 | Trial Unspecified | N | N | 240030611 | TRIAL |
| 240011500 | 240007696 | 1.55 | 78.2 | Disease modification (D) | 2018-01-21 | 2018-01-23 | Methotrexate intrathecal | N | N | 240030611 | METHOTREXATE INTRATHECAL |
| 240011501 | 240007696 | null | null | Neo-adjuvant (N) | 2016-01-17 | 2016-02-11 | NHL IntB NHL ritux2010 GpB COPADM R | N | N | 240030611 | NOT MATCHED |
| 240011502 | 240007696 | 1.77 | 74 | Curative (C) | 2016-05-28 | 2016-05-28 | AML Downs HA | N | N | 240030611 | NOT MATCHED |
| 240011503 | 240007696 | 1.66 | 60.1 | Palliative (P) | 2015-09-12 | 2015-09-17 | Bevacizumab 7.5mg/kg | N | N | 240030611 | BEVACIZUMAB |
| 240011504 | 240015279 | 1.58 | 81 | Palliative (P) | 2014-04-11 | 2014-04-13 | PACLITAXEL | 02 | N | 240030645 | PACLITAXEL |
| 240011505 | 240007698 | null | 45.6 | Palliative (P) | 2016-05-13 | 2016-05-13 | Bevacizumab+Carbo+Pacliaxel | N | N | 240030646 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240011506 | 240007698 | 1.6 | 89.8 | Curative (C) | 2015-09-02 | 2015-09-10 | BEVACIZUMAB + CARBO + PACLITAXEL | N | N | 240030646 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240011507 | 240007699 | 1.68 | 69.5 | Palliative (P) | 2018-05-10 | 2018-05-17 | Bevacizumab | 02 | null | 240030664 | BEVACIZUMAB |
| 240011508 | 240007701 | 1.95 | 56.6 | Palliative (P) | 2017-07-01 | 2017-09-21 | BEVACIZUMAB + CARBO + PACLITAXEL | N | N | 240030668 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240011509 | 240007702 | 1.7 | 70.6 | Curative (C) | 2016-07-27 | 2016-08-17 | Paclitaxel 7 day | N | N | 240030673 | PACLITAXEL |
| 240011510 | 240007702 | null | 74.3 | Disease modification (D) | 2014-10-26 | 2014-11-02 | Azacitidine | N | N | 240030673 | AZACITIDINE |
| 240011511 | 240007703 | null | null | Curative (C) | 2013-09-04 | 2013-09-13 | Trial Unspecified | N | N | 240030702 | TRIAL |
| 240011512 | 240012138 | 1.65 | 59.7 | Palliative (P) | null | 2018-04-13 | Bevacizumab 15mg/kg | 1 | null | 240030707 | BEVACIZUMAB |
| 240011513 | 240007706 | 1.75 | 36.8 | Disease modification (D) | 2017-01-03 | 2017-01-04 | Trial Unspecified | N | N | 240030712 | TRIAL |
| 240011514 | 240007707 | 1.81 | 108 | Palliative (P) | 2015-09-06 | 2015-09-17 | BEVACIZUMAB + CARBO + PACLITAXEL | Y | null | 240030716 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240011515 | 240007707 | 1.78 | 75.4 | Palliative (P) | 2017-01-05 | 2017-01-06 | Bevacizumab | 02 | N | 240030716 | BEVACIZUMAB |
| 240011516 | 240007708 | 1.8 | null | null | 2016-10-29 | 2016-11-26 | ETOPOSIDE + THIOTEPA | 2 | N | 240030721 | NOT MATCHED |
| 240011517 | 240007710 | 1.74 | 80.1 | Curative (C) | 2018-07-14 | 2018-07-20 | PACLITAXEL | N | N | 240030724 | PACLITAXEL |
| 240011518 | 240007710 | 1.64 | 107.6 | Curative (C) | 2018-11-17 | 2018-11-17 | CYTARABINE + LOMUSTINE + VINBLASTINE | 02 | N | 240030724 | NOT MATCHED |
| 240011519 | 240007713 | 1.46 | 79.6 | Palliative (P) | 2018-09-13 | 2018-09-14 | null | 02 | N | 240030736 | NOT MATCHED |
| 240011520 | 240007714 | 1.63 | null | Palliative (P) | 2017-12-22 | 2017-12-24 | Bevacizumab+Carbo+Pacliaxel | 01 | N | 240030739 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240011521 | 240007716 | 1.83 | 0 | null | 2016-03-15 | 2016-03-25 | Carboplatin AUC 2 - 5 | null | y | 240030739 | CARBOPLATIN |
| 240011522 | 240007717 | null | 67.9 | null | 2018-07-07 | 2018-07-16 | Bevacizumab+Carbo+Pacliaxel | N | N | 240030750 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240011523 | 240007718 | 1.65 | 95 | Palliative (P) | 2015-04-26 | 2015-05-19 | Azacitidine | 2 | null | 240030755 | AZACITIDINE |
| 240011524 | 240007719 | 1.8 | 80 | Curative (C) | 2015-06-14 | 2015-06-22 | Bevacizumab 15mg/kg | 02 | N | 240030756 | BEVACIZUMAB |
| 240011525 | 240012149 | 1.64 | 90 | Neo-adjuvant (N) | 2015-12-03 | 2015-12-08 | ALCL ALCL 99 Closed AM 1, 2 or 3 | Y | N | 240030756 | NOT MATCHED |
| 240011526 | 240012149 | 1.67 | null | Disease modification (D) | 2017-01-22 | 2017-02-04 | INTERLACE TRIAL | null | N | 240030756 | INTERLACE TRIAL |
| 240011527 | 240007725 | 1.76 | 71.7 | Curative (C) | 2018-01-26 | 2018-02-16 | Bevacizumab+Carbo+Pacliaxel | N | N | 240030767 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240011528 | 240007727 | 1.47 | 61.1 | Palliative (P) | 2014-09-03 | 2014-09-03 | Paclitaxel 7 day | N | N | 240030784 | PACLITAXEL |
| 240011529 | 240007727 | 1.67 | 55.1 | Curative (C) | 2016-10-23 | 2016-11-05 | CHOP - 21 days | null | y | 240030784 | CHOP |
| 240011530 | 240007729 | 1.76 | null | Disease modification (D) | 2014-12-31 | 2014-12-31 | null | N | N | 240030788 | NOT MATCHED |
| 240011531 | 240007730 | 1.62 | null | null | 2014-07-31 | 2014-08-07 | Trial Unspecified | N | N | 240030798 | TRIAL |
| 240011532 | 240007730 | 1.58 | 43.6 | Unknown (U) | 2017-06-20 | 2017-07-17 | Azacitidine | N | N | 240030798 | AZACITIDINE |
| 240011533 | 240007731 | 1.78 | 59.25 | Neo-adjuvant (N) | 2015-12-15 | 2015-12-23 | INTERLACE TRIAL | 2 | N | 240030803 | INTERLACE TRIAL |
| 240011534 | 240012155 | 1.66 | null | Curative (C) | 2015-11-02 | 2015-11-12 | BEVACIZUMAB + CARBO + PACLITAXEL | 02 | N | 240030813 | BEVACIZUMAB + CARBO + PACLITAXEL |
| 240011535 | 240014229 | 1.61 | 100 | Palliative (P) | 2016-03-07 | 2016-03-07 | INTERLACE TRIAL | 02 | N | 240030816 | INTERLACE TRIAL |